510(k) K253710

Dexcom G7 Continuous Glucose Monitoring (CGM) System, Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System by Dexcom, Inc. — Product Code QBJ

K253710 is an FDA 510(k) premarket notification submitted by Dexcom, Inc. for the device "Dexcom G7 Continuous Glucose Monitoring (CGM) System, Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System". The FDA issued a decision of Substantially Equivalent on Dec 17, 2025. The device falls under product code QBJ (Integrated Continuous Glucose Monitoring System, Factory Calibrated), a Class II device regulated under 21 CFR 862.1355. Dexcom, Inc. has 27 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Dec 17, 2025
Date Received
Nov 24, 2025
Clearance Type
Special
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Integrated Continuous Glucose Monitoring System, Factory Calibrated
Device Class
Class II
Regulation Number
862.1355
Review Panel
CH
Submission Type
510(k)

An integrated continuous glucose monitoring system (iCGM) is intended to automatically measure glucose in bodily fluids continuously or frequently for a specified period of time. iCGM systems are designed to reliably and securely transmit glucose measurement data to digitally connected devices, including automated insulin dosing systems, and are intended to be used alone or in conjunction with these digitally connected medical devices for the purpose of managing a disease or condition related to glycemic control.

Need the full FDA record for Dexcom, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K253710. Report a data issue: hello@regdatalab.com.